A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
Arteriosclerosis, Thrombosis and Vascular Biology
Background-Antidiabetic thiazolidinediones (TZDs), like rosiglitazone or pioglitazone, improve endothelial function in patients with type 2 diabetes or metabolic syndrome, but it is currently unknown, whether these beneficial effects of TZDs depend on their metabolic action or may be caused by direct effects on the endothelium. Therefore, the present study examined whether short-term rosiglitazone treatment influences endothelium-dependent vasodilation as well as serum levels of vasculardoi:10.1161/01.atv.0000176192.16951.9a pmid:16002742 fatcat:zki42jnhingdzcy2e62fifhwkq